![Michael Meluzio](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Meluzio
Comptroller/Controller/Auditor chez
CUE BIOPHARMA, INC.
Fortune : 1 M $ au 31/08/2026
Profil
Mr. Michael Meluzio, CPA, is a Chief Accounting Officer & Vice President at Cue Biopharma, Inc. Mr. Meluzio was previously employed as a Chief Financial & Accounting Officer by Kiora Pharmaceuticals, Inc. He received his undergraduate degree from Adelphi University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CUE BIOPHARMA, INC. 0,67 % | 13/08/2026 | 48 961 ( 0,67 % ) | 1 M $ | 31/08/2026 |
Postes actifs de Michael Meluzio
| Sociétés | Poste | Début |
|---|---|---|
| CUE BIOPHARMA, INC. | Comptroller/Controller/Auditor | 01/06/2026 |
Anciens postes connus de Michael Meluzio
| Sociétés | Poste | Fin |
|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Directeur Financier/CFO | 18/03/2022 |
Formation de Michael Meluzio
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
10
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Kiora Pharmaceuticals, Inc.
 Kiora Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for the treatment of ophthalmic diseases | Health Technology |
Adelphi University
 Adelphi University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cue Biopharma, Inc.
 Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
